Zafar K, Azuama O, Parveen N
Front Microbiol. 2024; 15:1459202.
PMID: 39345262
PMC: 11427371.
DOI: 10.3389/fmicb.2024.1459202.
Cameron D, Johnson L, Maloney E
Expert Rev Anti Infect Ther. 2014; 12(9):1103-35.
PMID: 25077519
PMC: 4196523.
DOI: 10.1586/14787210.2014.940900.
Atassi N, Cudkowicz M, Schoenfeld D
Amyotroph Lateral Scler. 2011; 12(4):272-7.
PMID: 21554030
PMC: 3138079.
DOI: 10.3109/17482968.2011.577786.
Jackson C, Boylan J, Frye J, Gherardini F
Int J Antimicrob Agents. 2007; 30(6):496-504.
PMID: 17905571
PMC: 2175076.
DOI: 10.1016/j.ijantimicag.2007.07.013.
Pachner A
Curr Treat Options Neurol. 2005; 7(2):167-170.
PMID: 15676120
DOI: 10.1007/s11940-005-0026-y.
[Clinical courses of acute and chronic neuroborreliosis following treatment with ceftriaxone].
Kaiser R
Nervenarzt. 2004; 75(6):553-7.
PMID: 15257378
DOI: 10.1007/s00115-003-1560-z.
Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment.
Straubinger R, Summers B, Chang Y, Appel M
J Clin Microbiol. 1997; 35(1):111-6.
PMID: 8968890
PMC: 229521.
DOI: 10.1128/jcm.35.1.111-116.1997.
Reversal of Borrelia burgdorferi associated dilated cardiomyopathy by antibiotic treatment?.
Gasser R, Fruhwald F, Schumacher M, Seinost G, Reisinger E, Eber B
Cardiovasc Drugs Ther. 1996; 10(3):351-60.
PMID: 8877079
DOI: 10.1007/BF02627960.
Treatment of Lyme arthritis.
Cimmino M, Moggiana G, Parisi M, Accardo S
Infection. 1996; 24(1):91-3.
PMID: 8852480
DOI: 10.1007/BF01780668.
In vitro activity of vancomycin against the spirochete Borrelia burgdorferi.
Dever L, Jorgensen J, Barbour A
Antimicrob Agents Chemother. 1993; 37(5):1115-21.
PMID: 8517700
PMC: 187913.
DOI: 10.1128/AAC.37.5.1115.
Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo.
Alder J, Mitten M, Jarvis K, Gupta P, Clement J
Antimicrob Agents Chemother. 1993; 37(6):1329-33.
PMID: 8328782
PMC: 187961.
DOI: 10.1128/AAC.37.6.1329.
Laboratory aspects of Lyme borreliosis.
Barbour A
Clin Microbiol Rev. 1988; 1(4):399-414.
PMID: 3069200
PMC: 358062.
DOI: 10.1128/CMR.1.4.399.
Lyme arthritis in Spain.
Nogueras A, Pouplana M, Galbe J, Segura F
Ann Rheum Dis. 1989; 48(1):82-3.
PMID: 2923510
PMC: 1003683.
DOI: 10.1136/ard.48.1.82.
Clinical pharmacokinetics of ceftriaxone.
Yuk J, Nightingale C, Quintiliani R
Clin Pharmacokinet. 1989; 17(4):223-35.
PMID: 2686882
DOI: 10.2165/00003088-198917040-00002.
Treatment of Lyme borreliosis. Randomized comparison of doxycycline and penicillin G.
Kohlhepp W, Oschmann P, MERTENS H
J Neurol. 1989; 236(8):464-9.
PMID: 2614491
DOI: 10.1007/BF00328508.
Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis.
Preac-Mursic V, Weber K, Pfister H, Wilske B, Gross B, Baumann A
Infection. 1989; 17(6):355-9.
PMID: 2613324
DOI: 10.1007/BF01645543.
Range of atrioventricular conduction disturbances in Lyme borreliosis: a report of four cases and review of other published reports.
van der Linde M, Crijns H, de Koning J, Hoogkamp-Korstanje J, de Graaf J, Piers D
Br Heart J. 1990; 63(3):162-8.
PMID: 2183859
PMC: 1024396.
DOI: 10.1136/hrt.63.3.162.
Cefotaxime versus penicillin in the late stage of Lyme disease--prospective, randomized therapeutic study.
Hassler D, Zoller L, Haude M, Hufnagel H, Heinrich F, Sonntag H
Infection. 1990; 18(1):16-20.
PMID: 2179134
DOI: 10.1007/BF01644175.
Lyme disease.
Rahn D, Malawista S
West J Med. 1991; 154(6):706-14.
PMID: 1877201
PMC: 1002871.
Long term treatment of chronic Lyme arthritis with benzathine penicillin.
Cimmino M, Accardo S
Ann Rheum Dis. 1992; 51(8):1007-8.
PMID: 1417107
PMC: 1004816.
DOI: 10.1136/ard.51.8.1007.
